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Foreword
Chronic critical limb ischemia is one of the most common causes of disability and hospitalization, and is a frequent illness in the industrialized world. There have been significant achievements in diagnostic procedures as well as in the medical, invasive, and surgical treatment of chronic critical limb ischemia in recent years. Vascular reconstruction remains the treatment of choice for patients with severe peripheral arterial occlusive disease. However, once thrombosis of the bypass has occurred, secondary procedures to restore the patency are complex and associated with 3 -5 patency rates of less than 50010. The ideal treatment in nonreconstructible peripheral arterial occlusive disease should allow the patient to retain his limb with no or minimal pain and to maintain a satisfactory level of independence.
Spinal cord stimulation was introduced two decades ago by She ally and Mortimer for the treatment of intractable pain. It gained increased interest and has subsequently been used in various fields of application. Cook, 1973, noticed an improvement in lower limb blood flow in patients who were being treated with SCS for symptoms related to multiple sclerosis. In the following years, several investigators noted pain relief and healing of ischemic ulcers in endstage vascular patients treated with SCS.
Consequently, considerable research effort was devoted to explaining the effects of SCS on pain and peripheral blood flow.
However, the selection of patients for this therapy was still largely empirical. On the other hand, the recent advances in research of the microcirculation emphasize the extremely complex pathophysiology of chronic critical limb ischemia and offers us, probably, the possibility to divide the patients into responders and nonresponders.
We are very grateful that expert clinical and experimental colleagues from around the world have joined us in the effort to provide a comprehensive book on the pathophysiology of pain and vascular pain, on the physiology behind spinal cord stimulation, on the pathophysiology of chronic critical limb ischemia and the clinical results of this innovative therapy.
This book is aimed at informing vascular surgeons and angiologists involved experimentally or clinically in studies with nonreconstructible vascular patients. The more sophisticated a method, the higher the individual expectations. However, every new method for the treatment of disabling disease has to be evaluated carefully. To encourage rational development and further discussion, insight into the individual method has to be broadened and the current "state of the art" has to be defined.
Cologne, March 1994
The Editors V
Welcoming Address
On behalf of the German Society for Surgery and the German Society for Vascular Surgery, it is an honor and a pleasure for me to welcome you in Cologne to participate in this symposium on spinal cord stimulation and its therapeutic value in peripheral arterial occlusion disease. This treatment is certainly innovative, and like each new procedure, this also poses some fundamental problems.
In about 1910, in Breslau (now Wroclaw), Poland, a young surgical assistant to the famous Professor Mikulicz-Radetzki suggested to his chief the proposal to perform open-chest surgery, in the pleural lower pressure area which seemed to exclude any surgical access. Mikulicz-Radetzki answered, "With this method you could appear as a sensation in a circus?' Afterwards, however, he recognized the importance of his assistant's proposal.
Another scenario: in 1929, a young surgical assisant read a paper at the annual congress of the German Society for Surgery and reported on self-experiments in catheterization of the right chamber of the heart. The chairman of this session blocked any discussion about this paper with similar words; he advised the speaker to appear as a circus attraction, and added that such experiments could certainly never be of any value for clinical medicine.
The irony of these two stories is that, first, Ferdinand Sauerbruch, one of the famous German surgeons of this century, who had invented the low-pressure chamber which enabled him to open the chest and operate on chest diseases, became the father of thoracic surgery.
Secondly, Werner Forssmann who had described his experiments on himself, introducing new diagnostic and therapeutic possibilities in cardiology and cardiosurgery, received the Nobel prize for Medicine in 1956. The moderator at the congress of the German Society of Surgery in 1929 was Ferdinand Sauerbruch. He gave Forssmann a real dressing-down, even though he himself had suffered a similar fate 20 years earlier.
The moral of these stories should be that even experts, or those who consider themselves to be experts, can be blind with regard to progressive development, especially in their speciality, and can therefore hinder scientific progress.
In the present day, endoscopic surgery is challenging the operating rooms of the world. One of its initiators was Kurt Sem, a gynecologist in Kiel, Germany, who was first humored and then attacked by prominent surgeons who called him a stubborn outsider. That was 10 years ago, and his perseverance has made it possible for this operative technique to succeed. This is yet another example of the difficulties facing innovative developments.
Let's return to electrical spinal cord stimulation. This method, a progeny of pacemaking in cardiac rhythm disorders, is certainly an innovative procedure and obviously faces the inherent problems of acknowledgment and acceptance. At present, VII we still have to answer a few questions: Do patients enjoy a real and lasting benefit from this treatment, and if yes, how, and to what extent? What is the cost-benefit relation? Have all these correlations been thoroughly examined?
Spinal cord stimulation presents a modern challenge in the treatment of peripheral arterial occlusive disease: it is a genuinely innovative procedure with a range of acceptance between enthusiastic encouragement and perfidious criticism.
Perhaps spinal cord stimulation has a tremendous future if it further develops to become a standard treatment in special indications. Let us try to determine if this will become reality. Our credo in innovational methods -should be to judge and measure the value of this new and, so far, unconventional therapeutic concept, not just with statistically highly significant findings, but also with patient satisfaction. Thus, the "old" German Society for Surgery and the "young" German Society for Vascular Surgery is meeting here in historic Cologne, to set new standards, present interesting lectures and discussions, to cite further progress in our therapeutic efforts, to enrich the palette of treatment procedures, and to elucidate positive results concerning value and effectiveness of this most interesting new way of treating peripheral arterial occlusive disease.
Thank you very much for your kind attention!
